Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1950 4
1952 1
1953 2
1954 2
1955 1
1957 1
1959 1
1960 5
1962 2
1963 2
1964 6
1965 4
1966 2
1967 4
1968 6
1969 7
1970 5
1971 4
1972 3
1973 9
1974 12
1975 14
1976 9
1977 17
1978 12
1979 17
1980 26
1981 21
1982 20
1983 30
1984 31
1985 42
1986 25
1987 37
1988 44
1989 44
1990 45
1991 40
1992 58
1993 54
1994 65
1995 77
1996 71
1997 81
1998 118
1999 89
2000 110
2001 122
2002 117
2003 125
2004 144
2005 150
2006 151
2007 156
2008 155
2009 179
2010 153
2011 167
2012 195
2013 176
2014 190
2015 195
2016 189
2017 190
2018 213
2019 196
2020 226
2021 236
2022 173
2023 171
2024 58

Text availability

Article attribute

Article type

Publication date

Search Results

4,803 results

Results by year

Filters applied: . Clear all
Page 1
Etiology and Outcomes of Thrombotic Microangiopathies.
Bayer G, von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Buchler M, Vigneau C, Fakhouri F, Halimi JM. Bayer G, et al. Clin J Am Soc Nephrol. 2019 Apr 5;14(4):557-566. doi: 10.2215/CJN.11470918. Epub 2019 Mar 12. Clin J Am Soc Nephrol. 2019. PMID: 30862697 Free PMC article.
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study.
Scully M, de la Rubia J, Pavenski K, Metjian A, Knöbl P, Peyvandi F, Cataland S, Coppo P, Kremer Hovinga JA, Minkue Mi Edou J, De Passos Sousa R, Callewaert F, Gunawardena S, Lin J. Scully M, et al. J Thromb Haemost. 2022 Dec;20(12):2810-2822. doi: 10.1111/jth.15892. Epub 2022 Oct 21. J Thromb Haemost. 2022. PMID: 36138517 Free PMC article. Clinical Trial.
Intravascular lymphomatosis.
Lui PC, Wong GK, Poon WS, Tse GM. Lui PC, et al. J Clin Pathol. 2003 Jun;56(6):468-70. doi: 10.1136/jcp.56.6.468. J Clin Pathol. 2003. PMID: 12783976 Free PMC article.
Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19.
Scutelnic A, van de Munckhof A, Krzywicka K, van Kammen MS, Lindgren E, Cordonnier C, Kleinig TJ, Field TS, Poli S, Lemmens R, Middeldorp S, Aaron S, Borhani-Haghighi A, Arauz A, Kremer Hovinga JA, Günther A, Putaala J, Wasay M, Conforto AB, de Sousa DA, Jood K, Tatlisumak T, Ferro JM, Coutinho JM, Arnold M, Heldner MR; Cerebral Venous Sinus Thrombosis with Thrombocytopenia Syndrome Study Group**. Scutelnic A, et al. Eur Stroke J. 2023 Dec;8(4):1001-1010. doi: 10.1177/23969873231185213. Epub 2023 Jul 11. Eur Stroke J. 2023. PMID: 37434312 Free PMC article.
The aim of our study was to investigate the differences in presentation, treatment, clinical course, complications, and outcome of CVST-VITT between women and men. ...Women were more severely affected at presentation, but clinical course and outcome did not differ b …
The aim of our study was to investigate the differences in presentation, treatment, clinical course, complications, and outcome of CV …
Post-varicella thrombocytopenic purpura.
Amir A, Gilad O, Yacobovich J, Scheuerman O, Tamary H, Garty BZ. Amir A, et al. Acta Paediatr. 2010 Sep;99(9):1385-8. doi: 10.1111/j.1651-2227.2010.01842.x. Acta Paediatr. 2010. PMID: 20456262
AIMS: The aim of the study was to characterize the clinical course of post-varicella idiopathic thrombocytopenic purpura (ITP) and to asses the risk of acquiring ITP after varicella infection. ...The average minimal platelet count was 9.5 109 platelets/L. Post-varicella IT …
AIMS: The aim of the study was to characterize the clinical course of post-varicella idiopathic thrombocytopenic purpura (ITP) and to …
Vasculitis from the pediatric perspective.
Brogan PA, Dillon MJ. Brogan PA, et al. Curr Rheumatol Rep. 2000 Oct;2(5):411-6. doi: 10.1007/s11926-000-0041-7. Curr Rheumatol Rep. 2000. PMID: 11123091 Review.
As in adults, there is a considerable degree of overlap between the various vasculitic syndromes in childhood. With modern therapeutic agents, the prognosis for many of the childhood vasculitides has improved; however, in spite of this, there remains a not inconsequential …
As in adults, there is a considerable degree of overlap between the various vasculitic syndromes in childhood. With modern therapeutic agent …
Thrombotic eosinophilic vasculitis.
Nakajima H, Nakamura T. Nakajima H, et al. Clin Exp Dermatol. 2009 Jul;34(5):e69-71. doi: 10.1111/j.1365-2230.2008.03178.x. Epub 2009 Apr 27. Clin Exp Dermatol. 2009. PMID: 19438524
Rituximab-induced toxicity.
Mumoli N, Cei M. Mumoli N, et al. QJM. 2011 Mar;104(3):265. doi: 10.1093/qjmed/hcq033. Epub 2010 Mar 12. QJM. 2011. PMID: 20228132 No abstract available.
4,803 results